Reactive cholecystitis as the leading sign of subacute perforation of the right ventricle with the electrode of an implantable cardioverter defibrillator

Subacute lead perforation of the right ven-tricle caused acute, reactive, acalculous cholecystis, which initially distracted the attention of physicians from the develop-ment of hematopericard. Implantation of a cardioverter defibrillator in a young patient after sudden cardiac arrest, but be-fore treatment of significant stenosis of the proximal left anterior descending artery, resulted in a life-threatening condition only 36 days after arrest. After removing the implantable cardioverter defibrillator, there was no sign of pathological cardiac rhythm disorders.

subacute lead perforation of the right ventricle, reactive acalculos cholecysti-tis 

1. Mendis SPP, Norrving B. Global Atlas on Cardiovascular Disease Prevention and Control. Geneva: World Health Organization, 2011.

2. Eckart RE, Shry EA, Burke AP, McNear JA, Appel DA, Castillo-Rojas LM, Avedissian L, Pearse LA, Potter RN, Tremaine L, Gentlesk PJ, Huffer L, Reich SS, Stevenson WG. Department of Defense Cardiovascular Death Registry G. Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. J Am Coll Cardiol 2011;58:1254–61.

3. Welch AR, Yaday P, Lingle K. Subacute right ventricular pacemaker lead perforation: often talked about in consent forms but rarely seen. Cardiac Rhytm Management 2011;2:442-5.

4. Haq SA, Heitner JF, Lee L, Kassotis JT. Late presentation of a lead perforation as a complication of permanent pacemaker inser-tion. Angiology 2008;59:619–21.

5. McChesney J, Northump PG, Bickston SJ. Acute acalculose cholecystitis associated with systemic sepsis and visceral arterial hypop-erfusion. Dig Dis Sci 2003;48:1960-7.

6. Ryu JK, Ryu KH, Kim KH. Clinical features of acute acalculous cholecystitis. J Clin Gastroenterol 2003;36:166–9.

7. Laborderie J, Barandon L, Ploux S. Management of subacute and delayed right ventricular perforation with a pacing or an implant-able cardioverter-defibrillator lead. Am J Cardiol 2008;102:1352–5.